Carillon Tower Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Carillon Tower Advisers’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$6.15M	Sell	49,014 -1,500	-3%	-$168K	0.04%	392
2020 Q3	$5.12M	Sell	50,514 -1,398	-3%	-$143K	0.07%	331
2020 Q2	$5.05M	Sell	51,912 -461,247	-90%	-$42.9M	0.04%	368
2020 Q1	$39.5M	Sell	513,159 -85,703	-14%	-$8.36M	0.39%	84
2019 Q4	$66.6M	Sell	598,862 -2,000	-0.3%	-$206K	0.44%	67
2019 Q3	$59.6M	Buy	600,862 +60,186	+11%	+$5.98M	0.42%	72
2019 Q2	$53.6M	Sell	540,676 -184,640	-25%	-$17.6M	0.37%	90
2019 Q1	$80M	Sell	725,316 -145,534	-17%	-$15.2M	0.57%	30
2018 Q4	$80.1M	Buy	870,850 +68,720	+9%	+$6.95M	0.68%	19
2018 Q3	$88.4M	Buy	802,130 +40,946	+5%	+$4.26M	0.63%	27
2018 Q2	$71.1M	Sell	761,184 -122,819	-14%	-$10.6M	0.56%	39
2018 Q1	$71.8M	Hold	884,003	–	–	0.56%	33
2017 Q4	$80.5K	Buy	+884,003	New	+$73.5M	0.86%	19

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Carillon Tower Advisers's PRAH Position: Q4 2020 in Review

Carillon Tower Advisers reduced its PRA Health Sciences, Inc. (PRAH) stake by 3% in Q4 2020, selling an estimated $168K and leaving 49,014 shares worth $6.15M. The position accounts for 0.04% of the portfolio, ranked #392.

Carillon Tower Advisers first reported a position in PRAH in Q4 2017 and has held it in 13 quarters since. The position peaked at $88.4M in Q3 2018. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

Carillon Tower Advisers held 49,014 shares of PRA Health Sciences, Inc. worth $6.15M as of Q4 2020.
Carillon Tower Advisers sold 1,500 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $168K.
PRA Health Sciences, Inc. made up 0.04% of Carillon Tower Advisers's portfolio in Q4 2020, its #392 holding.
Carillon Tower Advisers first reported a position in PRA Health Sciences, Inc. in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's PRA Health Sciences, Inc. position peaked at $88.4M in Q3 2018.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.